Etravirine (ETR)
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- In combination with other ARV agents for the treatment of HIV-1 infection in treatment-experienced pts with PIs, NRTIs, and NNRTI-resistant variants.
- Treatment-experienced HIV-infected pediatric patients (6 -18 years of age and weighing at least 16 kg).
NON-FDA APPROVED USES
- Potential for use in first-line therapy for pts infected with NNRTI-resistant virus (untested)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- In combination with other ARV agents for the treatment of HIV-1 infection in treatment-experienced pts with PIs, NRTIs, and NNRTI-resistant variants.
- Treatment-experienced HIV-infected pediatric patients (6 -18 years of age and weighing at least 16 kg).
NON-FDA APPROVED USES
- Potential for use in first-line therapy for pts infected with NNRTI-resistant virus (untested)
There's more to see -- the rest of this entry is available only to subscribers.